Trials / Sponsors / Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Academic / Other · 10 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed P Prostate Cancer	Phase 3	2022-08-30
Unknown	NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carc Infiltrating Bladder Urothelial Carcinoma	Phase 1 / Phase 2	2018-12-06
Completed	A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer Clear Cell Metastatic Renal Cell Carcinoma	Phase 2	2017-05-31
Completed	Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Prostate Cancer Metastatic	Phase 3	2017-05-05
Unknown	Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases Clear-cell Metastatic Renal Cell Carcinoma, Bone Metastases	Phase 1 / Phase 2	2016-10-01
Completed	Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer Breast Cancer	N/A	2016-09-01
Completed	Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Ev Clear-cell Renal Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma	Phase 2	2012-06-01
Completed	Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease Von Hippel-Lindau Disease	Phase 2	2010-03-01
Unknown	Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen Breast Neoplasms, Chemotherapy	Phase 1 / Phase 2	2006-03-01
Completed	Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma Recurrent Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder	Phase 2	2004-02-09